CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from Operating Activities:
Net loss	$ (2,686)	$ (172)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	2,151	1,301
Bad debt expense	104	122
Amortization of deferred financing costs	242	33
Amortization of debt discount	108	0
Loss on impairment/disposal of equipment	680	12
Stock-based compensation	861	448
Increase (decrease) attributable to changes in assets and liabilities:
Accounts receivable	39	(498)
Prepaid expenses and other current assets	306	(37)
Other assets	(278)	(22)
Accounts payable	91	(21)
Accrued expenses, sales taxes and regulatory fees	269	(352)
Customer deposits	(42)	25
Deferred revenue	(33)	(82)
Net cash provided by operating activities - continuing operations	1,812	757
Net cash used in operating activities - discontinued operations	0	(50)
Net cash provided by operating activities	1,812	707
Cash flows from Investing Activities:
Proceeds from sale of equipment	2	11
Purchases of property and equipment	(753)	(547)
Net cash used in investing activities	(751)	(536)
Cash flows from Financing Activities:
Proceeds from exercise of stock options	0	7
Payments related to preferred stock exchange	(106)	0
Principal payments for capital lease	(185)	(147)
Payments related to debt issuance	(157)	(199)
Net payments on revolving loan facility	(780)	0
Net cash used in financing activities	(1,228)	(339)
Decrease in cash and cash equivalents	(167)	(168)
Cash at beginning of period	2,218	1,818
Cash at end of period	2,051	1,650
Supplement disclosures of cash flow information:
Cash paid during the period for interest	858	43
Non-cash investing and financing activities:
Preferred stock dividends	25	0
Reduction of debt in connection with severance obligations related to acquisition of Affinity	240	0
Stock issued in connection with debt amendment recorded as debt discount	147	0
Acquisition of network equipment under capital lease	38	120
Preferred stock conversion and warrant exchange	$ 9,500	$ 130